@biovectis.com
Life Sciences R&D company developing, manufacturing and marketing specialised tools for • protein-protein, protein-nucleic acids and protein-ligand interaction analysis based on the ultra precise native electrophoresis (BlueNative and EMSA in 1D and 2D format) followed be a mass spectrometry, Cryo-EM , NMR and NGS • minor genetic variants discovery and detection • analytical and diagnostic market o volatile organic compounds table top analytical platform o human age estimation based on the epigenetic markers Internal drug discovery projects o Scutum O - analytical tools for autologous tumor cell vaccine development o Scutum N - recombinant viral vaccine against Newcastle disease for poultry (positive efficacy field data) o Appus - autoimmune disease candidate therapy positively validated on the animal model
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
BioVectis is a Life Sciences R&D company that specializes in the development, manufacturing, and marketing of specialized tools. These tools are designed for various applications such as protein-protein, protein-nucleic acids, and protein-ligand interaction analysis. They utilize ultra-precise native electrophoresis in both 1D and 2D formats, followed by mass spectrometry, Cryo-EM, NMR, and NGS technologies.
In addition, BioVectis offers services for minor genetic variants discovery and detection, as well as analytical and diagnostic solutions. These include a table-top analytical platform for volatile organic compounds, human age estimation based on epigenetic markers, and internal drug discovery projects. Their drug discovery projects encompass Scutum O, which focuses on analytical tools for autologous tumor cell vaccine development, Scutum N, a recombinant viral vaccine against Newcastle disease for poultry with positive efficacy field data, and Appus, a candidate therapy for autoimmune diseases positively validated on animal models.
BioVectis collaborates with academic partners to develop products for the Life Sciences R&D market and the analytical and diagnostic market. They also provide unique molecular biology tools for minor genetic variants discovery and detection, with applications in oncology and virology. With a wide range of innovative solutions, BioVectis aims to advance scientific research and improve healthcare outcomes.
Contact them at info@biovectis. com or +48 22 668 71 64
Company Type
Privately Held
Company Size
2-10
Year Founded
2002
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online